Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10
Published July 17, 2013 · Recall initiated: May 13, 2013
Summary
FDA records drug Class III recall D-691-2013, published July 17, 2013 and initiated May 13, 2013. Recalling firm: West-ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: Lot PLNJ1201 -16,880 vials ; Lot PLNJ1202 - 16,960 vials; Lot: Lot PLNJ1201 APRIL 2014 Lot PLNJ1202 MAY 2014. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)
What to do
Voluntary: Firm initiated · Letter
Get an email if NICARDIPINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NICARDIPINE HYDROCHLORIDE
- Manufacturer
- West-ward Pharmaceutical Corp.
- Distributor
- Nationwide
- Lot
- Lot PLNJ1201 APRIL 2014 Lot PLNJ1202 MAY 2014
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDCAugust 26, 2026
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for:May 7, 2025
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, AmericanMay 7, 2025
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, ForMay 29, 2024
- FDACamila (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, RxJuly 17, 2013
- FDAAcetyl-D-Glucosamine w/Chondroitin 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FLJuly 17, 2013
Questions about this recall
Was Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials, Rx Only, Mfd. by Exela Pharma Sciences, LLC, Lenoir, NC, Dist. by: West-ward Pharmaceutical Corp., Eatontown, NJ --- NDC 0143-9689-10 recalled?
Yes. FDA published recall D-691-2013 on July 17, 2013. Reported hazard: Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NICARDIPINE HYDROCHLORIDE.